Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales ...

Hims & Hers Health, Inc. reported record Q3 '24 revenues of over $400 million, beating estimates by nearly $19 million, and ...

Hims & Hers' strong Q3 results and 77% y/y revenue growth demonstrate its robust business, justifying a continued strong buy ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...

It was Donald Trump and Kamala Harris’s last chance to speak directly to the American people who have not yet decided who ...

Ashby Kilgore was a bit apprehensive when she retired after 46 years in the public school system. “It was like, ‘What the ...

María Camila Zarta tells TODAY.com that as a Colombian immigrant seeing the singer felt like he gave her a piece of her ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

Hims & Hers Health, Inc. ( (HIMS) ) has released its Q3 earnings. Here is a breakdown of the information Hims & Hers Health, Inc.

Martha Stewart is not big on sharing her feelings. To the millions who greedily gobbled up scuttlebutt about her legendary ...

Read on for updates about Heidi Klum's 2024 Halloween party including what she wore and other guests wore. Here are photos of ...